AU720243B2 - Method for the prevention and treatment of mastitis - Google Patents

Method for the prevention and treatment of mastitis Download PDF

Info

Publication number
AU720243B2
AU720243B2 AU33410/97A AU3341097A AU720243B2 AU 720243 B2 AU720243 B2 AU 720243B2 AU 33410/97 A AU33410/97 A AU 33410/97A AU 3341097 A AU3341097 A AU 3341097A AU 720243 B2 AU720243 B2 AU 720243B2
Authority
AU
Australia
Prior art keywords
micrococcin
antibiotic
mastitis
milk
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU33410/97A
Other languages
English (en)
Other versions
AU3341097A (en
Inventor
Catherine Georges
John Edmondson Peel
Bruno Suri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU3341097A publication Critical patent/AU3341097A/en
Application granted granted Critical
Publication of AU720243B2 publication Critical patent/AU720243B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/05—Treating milk before coagulation; Separating whey from curd
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pest Control & Pesticides (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Agronomy & Crop Science (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
AU33410/97A 1996-06-20 1997-06-19 Method for the prevention and treatment of mastitis Ceased AU720243B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96810415 1996-06-20
EP96810415 1996-06-20
PCT/EP1997/003212 WO1997048408A2 (en) 1996-06-20 1997-06-19 Method for the prevention and treatment of mastitis

Publications (2)

Publication Number Publication Date
AU3341097A AU3341097A (en) 1998-01-07
AU720243B2 true AU720243B2 (en) 2000-05-25

Family

ID=8225635

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33410/97A Ceased AU720243B2 (en) 1996-06-20 1997-06-19 Method for the prevention and treatment of mastitis

Country Status (14)

Country Link
US (1) US6187800B1 (enExample)
EP (1) EP0934075B1 (enExample)
JP (1) JP2000513348A (enExample)
CN (1) CN1119170C (enExample)
AT (1) ATE215378T1 (enExample)
AU (1) AU720243B2 (enExample)
BR (1) BR9709812A (enExample)
CA (1) CA2251779A1 (enExample)
DE (1) DE69711661T2 (enExample)
DK (1) DK0934075T3 (enExample)
ES (1) ES2175425T3 (enExample)
IL (1) IL126489A0 (enExample)
PT (1) PT934075E (enExample)
WO (1) WO1997048408A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US6638902B2 (en) * 2001-02-01 2003-10-28 Ecolab Inc. Stable solid enzyme compositions and methods employing them
US7030085B2 (en) 2001-03-13 2006-04-18 Astellas Pharma Inc Thiopeptide compounds
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
WO2004002451A1 (fr) * 2002-06-28 2004-01-08 Fang Chen Suppositoire a liberation controlee utilise dans un canal secreteur de lait
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
NZ539076A (en) * 2005-03-29 2008-05-30 Blis Technologies Ltd Skin treatment compositions
CN100368016C (zh) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 治疗奶牛乳房炎的乳房灌注液及其制备方法
SG166115A1 (en) * 2005-09-30 2010-11-29 Boehringer Ingelheim Vetmed Pharmaceutical preparation containing meloxicam
CN100448480C (zh) * 2005-11-09 2009-01-07 北京大北农科技集团股份有限公司 治疗奶牛乳房炎的乳房用无菌粉针制剂及其制备方法
EP2079477B1 (en) * 2006-10-10 2017-07-26 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
KR20120005497A (ko) 2009-04-08 2012-01-16 위스콘신 얼럼나이 리서어치 화운데이션 유방내 유두 밀봉 제제 및 이를 사용하여 숙성된 치즈에서 시각적 결함을 감소 또는 제거시키는 방법
US9101529B2 (en) 2009-10-12 2015-08-11 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
EP2361632B1 (en) * 2010-02-19 2014-03-19 Protectimmun GmbH Specific environmental bacteria for the protection from and/or the treatment of allergic, chronic inflammatory and/or autoimmune diseases
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
US9943500B2 (en) * 2013-02-08 2018-04-17 Luoda Pharma Pty Ltd Methods of treating topical microbial infections
MX375254B (es) * 2013-02-08 2025-03-06 Luoda Pharma Ltd Una composición antimicrobiana farmacéutica o veterinaria intramamaria que comprende un poliéter ionóforo, o un uso de la misma para tratar mastitis.
TW201607534A (zh) * 2013-10-31 2016-03-01 皮拉馬爾企業有限公司 治療困難梭狀芽孢桿菌相關感染用硫肽化合物
CN110139638A (zh) * 2016-12-27 2019-08-16 高露洁-棕榄公司 止汗剂/除臭剂组合物
GB202014427D0 (en) * 2020-09-14 2020-10-28 Norwegian Univ Of Life Sciences Composition and use
WO2022245150A1 (ko) * 2021-05-21 2022-11-24 주식회사 에이엔제이사이언스 마크로코신 화합물을 포함하는 약학적 조성물 및 마크로코신 화합물의 제조방법
CN117597138A (zh) * 2021-05-21 2024-02-23 A&J科学有限公司 包含微球菌素化合物的药物组合物以及制备微球菌素化合物的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005844A1 (en) * 1993-08-20 1995-03-02 Ciba-Geigy Ag Method for the prevention and treatment of bovine mastitis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005844A1 (en) * 1993-08-20 1995-03-02 Ciba-Geigy Ag Method for the prevention and treatment of bovine mastitis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MERCK INDEX, 11TH EDITION, PAGE 972 *
NATURE, VOLUME 178, (1956), 44-45 *

Also Published As

Publication number Publication date
CN1119170C (zh) 2003-08-27
JP2000513348A (ja) 2000-10-10
CA2251779A1 (en) 1997-12-24
IL126489A0 (en) 1999-08-17
PT934075E (pt) 2002-08-30
BR9709812A (pt) 1999-08-10
ES2175425T3 (es) 2002-11-16
DE69711661T2 (de) 2002-10-17
CN1222081A (zh) 1999-07-07
ATE215378T1 (de) 2002-04-15
DK0934075T3 (da) 2002-06-10
DE69711661D1 (de) 2002-05-08
EP0934075A2 (en) 1999-08-11
WO1997048408A3 (en) 1998-02-19
US6187800B1 (en) 2001-02-13
EP0934075B1 (en) 2002-04-03
AU3341097A (en) 1998-01-07
WO1997048408A2 (en) 1997-12-24

Similar Documents

Publication Publication Date Title
EP0934075B1 (en) Micrococcin atibiotic for the prevention and treatment of mastitis
US6254881B1 (en) Antiinfective free intramammary veterinary composition
Oldham et al. Lysostaphin: use of a recombinant bactericidal enzyme as a mastitis therapeutic
EP0323109B1 (en) Treatment of mastitis and applicator therefor
Owens et al. Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation
Lacy-Hulbert et al. Physical characteristics of the bovine teat canal and their influence on susceptibility to streptococcal infection
US5710124A (en) Method for combatting bovine mastitis
WO1995030751A1 (en) Lanthionine-containing antimicrobial compound
Watkins et al. The effect of the intra-mammary inoculation of lactating ewes with Pasteurella haemolytica isolates from different sources
JP6921805B2 (ja) ウシ乳腺炎の治療に使用するためのリソバクチン
Oliver Growth of Staphylococcus aureus and Streptococcus species in bovine mammary secretions during the nonlactating and peripartum periods following intramammary infusion of lipopolysaccharide at cessation of milking
KR20190097293A (ko) 인간 이외의 동물에서 그람 양성균 및 그람 음성균에 의해 유발된 질병에 대한 리소박틴과 아미노글리코시드의 조합

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)